Hepatitis B and human immunodeficiency virus coinfection.
about
Insights into human immunodeficiency virus-hepatitis B virus co-infection in IndiaHepatitis B and A vaccination in HIV-infected adults: A reviewHepatitis B and human immunodeficiency virus co-infectionThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureThe evolving scenario of non-AIDS-defining cancers: challenges and opportunities of careManagement of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesHIV infection, aging, and immune function: implications for cancer risk and preventionComparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border regionAssociations between HIV and human pathways revealed by protein-protein interactions and correlated gene expression profilesGenotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern AfricaAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Diagnosis of viral hepatitis.HIV outcomes in Hepatitis B virus coinfected individuals on HAARTDiscrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012.Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in BrazilStrategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1Liver disease in the HIV-infected individual.Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.Detection of highly prevalent hepatitis B virus co-infection with HIV in Indonesia.Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy.HBV and HIV co-infection: Impact on liver pathobiology and therapeutic approaches.HIV and HCV coinfection: prevalence, associated factors and genotype characterization in the Midwest Region of Brazil.Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.Effect of hepatitis-B virus co-infection on CD4 cell count and liver function of HIV infected patients.Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional studyMolecular characterization of HBV strains circulating among the treatment-naive HIV/HBV co-infected patients of eastern India.Occurrence of HBV/HIV coinfection by laboratory values in Roma, LesothoIncidence of HIV and the prevalence of HIV, hepatitis B and syphilis among youths in Maputo, Mozambique: a cohort studyThe effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infectionHuman immunodeficiency virus infects human seminal vesicles in vitro and in vivo.Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the Far North Region of Cameroon.Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconvertersHepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya.Hepatitis B virus epidemiology.HIV-HBV coinfection--a global challengeHepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a DecadeClinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort.Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
P2860
Q26797826-22488CAE-6699-4986-A670-1EE9FB26A558Q26799782-F8F5A251-1B3F-4291-8F5F-0693639314EBQ26822862-DBA1CC75-B3C7-4EC8-A794-4F809546F640Q26864344-5B27E416-F8ED-4339-88C8-2E2BA8D9680FQ26991549-8335A15A-4BE9-42A2-941D-B641D8D819B5Q27000080-1078A9E8-5A8C-4EA4-AC67-399CF5314F9DQ27004165-CCFD1C1F-4EB6-4F6D-88C1-D8D84C69D602Q28476802-E8BE2E7B-AD65-43A8-B83F-93EF31468802Q28481666-52A35D12-15F2-48AC-880D-0BFCC03DAD1AQ28484102-B6CC1060-0EF2-45AF-952A-10F2B72926B4Q30391932-D53D9DA9-028A-4D12-B479-D24B53B6A379Q33557877-05EA35B8-BDFE-4646-997E-D4B49A72D7B2Q33665820-0C3DA46D-7303-4890-9ED7-430BC33FE5B0Q33853905-484FC44E-8A35-4C6A-8952-8568FB94B3CCQ34024622-56F96C69-7D53-41BE-B366-B600DFC0B836Q34077801-A8EBD7BD-D195-43AD-ADF9-9FBB16D53D4EQ34380326-44B54F5F-820D-4D9B-A94F-0A728811C310Q34405008-91BF0BE7-E688-421A-B0EF-9FFAEBA64136Q34437586-F93E076A-4A4A-4817-A4FB-9CC44E73D990Q34556226-3F97FCC3-F910-4E43-8620-8B72C9E27599Q34675557-C1E936B0-D5D8-4EE8-A85B-7EE324A52AEFQ34966832-594E0CBD-E14E-4922-A2EF-41A68389D55BQ34977282-73D08982-B422-47E0-81D3-7C8BF16FCE34Q34982182-AD328FB3-8C7C-49CC-9C40-9D9C00884735Q35026139-4475A649-8391-46B8-B41D-D31C8915BA74Q35055172-D955FF09-8EE9-4AE2-ABFB-E83646828825Q35104764-4767BD58-30A8-4D45-B57A-B7835AF57271Q35109040-22833FA3-659F-4432-89CB-C3DC1E34AEBDQ35151271-D1FE8575-5E33-4D83-9250-44CC54D8B4D9Q35208491-0BAA9971-6F38-4022-AF44-2A6BA9F0C575Q35454587-6C065B63-B7E3-4E80-A7CA-5A015E03C4A7Q35474074-C2544109-3412-4F38-BD57-F368E810787BQ35596063-0095BA03-3EB9-4BDE-BBC4-F47A8FA86925Q35628651-03D34903-8C5E-47AA-A814-F48A92AE49D1Q35661832-18BDB03F-1EAB-45CE-89EF-1C46A992B59EQ35663834-7AB2797A-3CD9-4872-84B8-A796CAA82DA2Q35678473-2072323A-56D2-47DD-8605-BED8571F8169Q35775807-04560B6A-F2C5-4F59-BC38-6D5CB4865B81Q35873534-12304EEA-260A-45DF-A148-B4433BA302E6Q35892317-A0649F50-0F82-44A3-BEEA-352E21C99E1A
P2860
Hepatitis B and human immunodeficiency virus coinfection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B and human immunodeficiency virus coinfection.
@en
Hepatitis B and human immunodeficiency virus coinfection.
@nl
type
label
Hepatitis B and human immunodeficiency virus coinfection.
@en
Hepatitis B and human immunodeficiency virus coinfection.
@nl
prefLabel
Hepatitis B and human immunodeficiency virus coinfection.
@en
Hepatitis B and human immunodeficiency virus coinfection.
@nl
P356
P1433
P1476
Hepatitis B and human immunodeficiency virus coinfection.
@en
P2093
Chloe L Thio
P2860
P304
P356
10.1002/HEP.22883
P407
P433
P577
2009-05-01T00:00:00Z